Insights On Downstream Manufacturing

  1. USP <788> Revisions And Why Packaging Matters More Than Ever 5/12/2026

    Prepare for the upcoming USP <788> revisions by strengthening your particulate control strategy to support regulatory compliance, product quality, and patient safety across injectable drug products.

  2. Why Lower Endotoxin Levels Matter: Raising The Bar For Patient Safety And Product Quality 5/12/2026

    Strengthen patient safety and regulatory compliance with comprehensive endotoxin control strategies designed to support the evolving demands of injectable and advanced pharmaceutical products.

  3. Design Scalable Downstream Processes With Practical Strategies 5/11/2026

    Downstream purification is becoming more complex as new modalities enter development. Learn how advanced analytics and chromatography strategies can support scalable, confident process development.

  4. Improving LVV And AAV Yield Through Cargo Gene Silencing 5/7/2026

    Silencing cargo gene expression during LVV and AAV production improves cell health, reduces impurities, and significantly increases vector yield for cytotoxic and difficult‑to‑manufacture transgenes.

  5. How Dermal Delivery Platforms Are Transforming Tomorrows For Patients 5/7/2026

    Skin delivery platforms expand therapies by boosting convenience, stability, and adherence. Integrated formulation, device, and manufacturing development is key to confidently scale.

  6. Native SEC-MALS Characterization Using A Chromatography Data System 5/7/2026

    Native SEC‑MALS offers a calibration‑free way to accurately characterize peptide oligomers, helping scientists distinguish true higher‑order structures while avoiding bias.

  7. Microflow Columns Boost GLP-1 Sensitivity And Reduce Solvent 5/7/2026

    Microflow chromatography offers a practical way to boost GLP‑1 assay sensitivity while cutting solvent use. See how 1.0 mm columns improve peak response without sacrificing chromatographic performance.

  8. Aligning Upstream And Downstream Development (Part 2) 5/5/2026

    In Part 2 of this conversation on “Better Biopharma,” panelists from the Bioprocess Online Live event “Optimizing Process Development Through Upstream And Downstream Integration” continue their discussion about how upstream and downstream development teams can work together to accelerate timelines and reduce risk and bottlenecks in process development.

  9. 3 Critical UF/DF Challenges And How To Solve Them 5/4/2026

    High‑concentration mAbs change how UF/DF behaves. Learn how modern TFF platforms help address these challenges and maintain control as formulations move beyond traditional limits.

  10. Why Pharmaceutical Scientists Trust The Discovery Core Rheometer 5/1/2026

    Drug formulations demand more than single‑point viscosity data. Explore how rheology reveals stability, flow, and structural behavior across suspensions, topicals, and injectables.